Limited M1 disease: A significant prognostic factor for stage IV breast cancer

Annals of Surgical Oncology

Volumn 19, Issue 9, 2012, Pages 3028-3034

  Nguyen, David H A ^a,b   Truong, Pauline T ^a,c   Walter, Caroline V ^a   Hayashi, Emily ^a   Christie, Jennifer L ^a   Alexander, Cheryl ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIMITED M1 DISEASE; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TUMOR VOLUME;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PELVIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; SOFT TISSUE NEOPLASMS; TERMINOLOGY AS TOPIC; THORACIC NEOPLASMS;

EID: 84867402946     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2333-3     Document Type: Article

References (35)

1. Harris JR, Morrow M, Bonnadonna G. Cancer of the breast. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice in oncology. 4th ed. Philadelphia: Lippincott, 1993. p. 1264-332.
2. Rizzieri DA, Vredenburgh JJ, Jones R, et al. Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. J Clin Oncol. 1999;17:3064-74.
3. Dunphy FR, Spitzer G, Rossiter Fornoff JE, et al. Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer. 1994;73:2157-67.
4. Singletary SE, Walsh G, Vauthey JN, et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist. 2003;8:241-51.
5. Hortobagyi GN. Can we cure limited metastatic breast cancer? J Clin Oncol. 2001;20:620-3.
6. Tait CR, Waterworth A, Loncaster J. The oligometastatic state in breast cancer: hypothesis or reality? Breast. 2005;14:87-93.
7. Carey Sampson M, Katz A, Constine LS. Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol. 2006;16:67-76.
8. Nguyen DH, Truong PT. A debate on locoregional treatment of the primary tumor in patients presenting with stage IV breast cancer. Expert Rev Anticancer Ther. 2011;11:1913-22.
9. Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat. 2009;115:601-8.
10. Singh D, Yi WS, Brasacchio RA, et al. Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys. 2004;58:3-10.
11. Salama JK, Hasselle MD, Chmura SJ, et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2011. doi:10.1002/cncr.26611.
12. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-83.
13. Downey RJ, Ng KK. The management of non-small-cell lung cancer with oligometastases. Chest Surg Clin N Am. 2001;11:121-32.
14. Staehler MD, Kruse J, Haseke N, et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 2010;28:543-7.
15. Wasif N, Bagaria SP, Ray P, Morton DL. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol. 2011;104:111-5.
16. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8-10.
17. Tomiak E, Piccart M, Mignolet F, et al. Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study. Eur J Cancer. 1996;32A: 1876-87.
18. Greenberg PA, Hortobagyi GN, Smith TL, et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996;14:2197-205.
19. Yamamoto N, Watanabe T, Katsumata N, et al. Construction and validation of a practical prognostic index for patients with metastatic breast cancer. J Clin Oncol. 1998;16:2401-8.
20. Nieto Y, Nawaz S, Jones RB, et al. Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Oncol. 2002;20:707-18.
21. Niibe Y, Kuranami M, Matsunaga K, et al. Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence. Anticancer Res. 2008;28(6B):3929-31.
22. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:1516-22.
23. Milano MT, Philip A, Okunieff P. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. Int J Radiat Oncol Biol Phys. 2009;73:832-7.
24. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620-6.
25. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24:2743-9.
26. Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol. 2007;14:2187-94.
27. Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site metastasis. Ann Surg Oncol. 2007;14:3345-51.
28. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13:776-82.
29. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247:732-8.
30. Le Scodan R, Stevens D, Brian E, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol. 2009;27:1375-81.
31. Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al. Surgical resection of the primary tumor is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol. 2009;35:1146-51.
32. Nguyen DH, Truong PT, Alexander C, et al. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis. Int J Radiat Oncol Biol Phys. 2012. doi:10.1016/j.ijrobp. 2011.11.046.
33. Badwe R, Hawaldar R, Khare A, Nadkarni M, Jalali R, Parmar V. Role of local-regional treatment in metastatic breast cancer at presentation: a randomized trial. 2008. http://www.asco.org/ascov2/Meetings/abstracts? &vmview=abst-detail-view&confID=58&abstractsID=40329. Accessed 17 Dec. 2011.
34. Soran A, Ozbas S, Kelsey SF, Gulluoglu BM. Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Diseases. Breast J. 2009;15:399-403.
35. Khan SA. Early surgery or standard palliative therapy in treating patients with stage IV breast cancer. 2010. http://www.cancer.gov/ clinicaltrials/. Accessed 17 Dec. 2011.